V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250001557 | 250007598 | 1.71 | 95.5 | null | null | 2020-03-12 | CARBOPLATIN + GEMCITABINE | null | null | CARBOPLATIN + GEMCITABINE | 100077758 |
| 250001558 | 250007599 | 0.02 | 80.4 | null | null | 2016-11-07 | CISPLATIN + GEMCITABINE | null | null | PEMBROLIZUMAB | 101773875 |
| 250001563 | 250007600 | 1.9 | 72.55 | null | null | 2021-04-13 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100964262 |
| 250001571 | 250007602 | 1.6 | 58.9 | null | null | 2020-01-13 | null | null | null | CARBOPLATIN + GEMCITABINE | 101049242 |
| 250001593 | 250007605 | 1.59 | 60.35 | null | null | 2017-08-16 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101457058 |
| 250001596 | 250007606 | 1.58 | null | Palliative (P) | 2019-07-16 | 2019-08-07 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100349637 |
| 250001609 | 250007608 | 1.75 | 80.4 | null | null | 2020-01-11 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100967364 |
| 250001623 | 250007610 | 1.73 | 76.1 | Palliative (P) | 2017-05-21 | 2017-06-18 | null | 02 | N | CARBOPLATIN + GEMCITABINE | 100527017 |
| 250001630 | 250007611 | 1.72 | 70.2 | null | null | 2017-09-12 | NIVOLUMAB | null | null | NIVOLUMAB | 101443686 |
| 250001635 | 250007613 | 1.62 | 47 | null | null | 2016-07-17 | NIVOLUMAB | null | null | NIVOLUMAB | 101166001 |
| 250001639 | 250007614 | 1.76 | 78.8 | Palliative (P) | 2019-06-01 | 2019-06-12 | null | 02 | N | CARBOPLATIN + GEMCITABINE | 101341015 |
| 250001645 | 250007616 | 1.6 | 117 | null | null | 2022-04-01 | GemCarbo Days 1+8 | null | null | CARBOPLATIN + GEMCITABINE | 100448477 |
| 250001653 | 250007617 | 1.66 | null | 03 | 2017-06-28 | 2017-07-12 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101022235 |
| 250001654 | 250007618 | 1.63 | 82.6 | null | null | 2017-01-15 | null | null | null | CARBOPLATIN + GEMCITABINE | 101137929 |
| 250001680 | 250007625 | 1.82 | 80.2 | null | null | 2018-05-02 | null | null | null | PEMBROLIZUMAB | 101211758 |
| 250001692 | 250007629 | 1.83 | 89 | null | null | 2020-10-19 | CARBOPLATIN + GEMCITABINE | null | null | CARBOPLATIN + GEMCITABINE | 100928227 |
| 250001727 | 250007635 | 1.67 | 90 | Palliative (P) | 2016-10-28 | 2016-11-09 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100760464 |
| 250001753 | 250007637 | 1.65 | null | null | 2020-06-24 | 2020-07-05 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101470849 |
| 250001764 | 250007639 | 1.67 | 80 | null | null | 2017-01-25 | null | null | null | CARBOPLATIN + GEMCITABINE | 100076116 |
| 250001779 | 250007641 | 1.69 | 66 | null | null | 2017-02-15 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101860889 |
| 250001800 | 250007647 | 1.69 | 70.2 | null | null | 2018-10-30 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | NIVOLUMAB | 101657484 |
| 250001824 | 250007652 | 1.8 | 69.8 | null | null | 2018-11-28 | null | null | null | CISPLATIN + GEMCITABINE | 100185255 |
| 250001829 | 250007654 | 1.76 | 57.6 | Palliative (P) | 2020-07-05 | 2020-07-18 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 101181842 |
| 250001831 | 250007655 | 1.68 | 85.6 | null | null | 2019-11-03 | NIVOLUMAB | null | null | NIVOLUMAB | 101320867 |
| 250001833 | 250007656 | 1.66 | 52 | null | null | 2019-09-14 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101439724 |
| 250001858 | 250007659 | 1.62 | 74.8 | null | null | 2021-07-15 | NIVOLUMAB | null | null | NIVOLUMAB | 101586075 |
| 250001894 | 250007666 | 0 | 67 | Palliative (P) | 2020-02-19 | 2020-03-06 | NIVOLUMAB | 01 | N | NIVOLUMAB | 101090158 |
| 250001895 | 250007667 | 1.69 | 131.2 | null | null | 2020-03-01 | NIVOLUMAB | null | null | NIVOLUMAB | 101272575 |
| 250001899 | 250007669 | 1.59 | 54.4 | null | null | 2019-01-18 | CISPLATIN + GEMCITABINE | null | null | NIVOLUMAB | 100191787 |
| 250001908 | 250007672 | 1.56 | 128 | null | null | 2022-05-23 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100311467 |
| 250001913 | 250007673 | 1.61 | 59.4 | null | null | 2019-05-25 | null | null | null | NIVOLUMAB | 100856786 |
| 250001938 | 250007676 | 0 | 61.3 | null | null | 2020-04-20 | null | null | null | NIVOLUMAB | 101398065 |
| 250001945 | 250007678 | 1.74 | 72 | null | null | 2017-10-10 | null | null | null | CISPLATIN + GEMCITABINE | 100171769 |
| 250001954 | 250007680 | 1.55 | null | null | null | 2020-02-11 | null | null | null | CARBOPLATIN + GEMCITABINE | 101216449 |
| 250001958 | 250007681 | 1.78 | 61.2 | null | null | 2018-10-29 | null | null | null | PEMBROLIZUMAB | 101530452 |
| 250001973 | 250007688 | 1.84 | 102.3 | Palliative (P) | 2021-06-27 | 2021-06-27 | CISPLATIN + GEMCITABINE | 02 | N | PEMBROLIZUMAB | 100997981 |
| 250002000 | 250007694 | 1.83 | 66.8 | null | 2021-08-19 | 2021-10-22 | NB HRNBL-1 COJEC Ind COURSE A | 02 | N | NB HRNBL-1 ISOTRETINOIN | 100591731 |
| 250002005 | 250007695 | null | null | null | null | 2019-03-04 | ICON8B TRIAL | null | null | NB HRNBL-1 COJEC IND COURSE C | 100520456 |
| 250002009 | 250007697 | null | null | Palliative (P) | null | 2021-08-29 | DABRAFENIB + TRAMETINIB | null | N | ETOPOSIDE + IFOSFAMIDE | 100776673 |
| 250002027 | 250007699 | null | null | Curative (C) | 2018-10-28 | 2018-10-28 | Cisplatin + Radiotherapy | 02 | null | TIVOZANIB | 101518277 |
| 250002037 | 250007702 | 0 | 65.6 | Palliative (P) | null | 2020-01-07 | Dinutuximab Beta | 02 | N | FLUOROURACIL + IRINOTECAN | 100482337 |
| 250002038 | 250007703 | 1.84 | 81.8 | null | 2017-12-08 | 2018-05-14 | null | 02 | N | TRIAL UNSPECIFIED | 100690602 |
| 250002045 | 250007704 | 1.78 | 10.8 | Palliative (P) | 2017-08-06 | 2018-01-02 | null | N | N | CABOZANTINIB | 100703044 |
| 250002057 | 250007710 | 1.69 | 127 | Palliative (P) | null | 2020-09-10 | Atezolizumab | 02 | N | ATEZOLIZUMAB | 101523781 |
| 250002058 | 250007711 | 1.31 | 76.3 | null | 2019-03-07 | 2019-07-11 | null | 02 | null | NOT MATCHED | 101563165 |
| 250002062 | 250007715 | 0.85 | 53.9 | Palliative (P) | 2013-11-23 | 2013-12-14 | null | 01 | null | TRIAL UNSPECIFIED | 100922567 |
| 250002069 | 250007717 | 1.52 | 54.5 | Palliative (P) | 2019-08-10 | 2019-09-12 | null | null | N | ATEZOLIZUMAB | 100019413 |
| 250002071 | 250007718 | null | null | Palliative (P) | 2019-10-28 | 2019-11-28 | null | 02 | N | CISPLATIN + FLUOROURACIL | 101152089 |
| 250002076 | 250007719 | 1.56 | null | null | 2021-06-03 | 2021-06-26 | Trial Unspecified | 02 | null | ATEZOLIZUMAB | 100996042 |
| 250002078 | 250007721 | null | null | null | null | 2021-01-16 | Imatinib 400mg | null | null | IMATINIB | 100686510 |